Catalyst Wire Dossier Catalyst Wire Dossier

TRUXIMA

rituximab-abbs · Cephalon, Inc.
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for TRUXIMA, covering 2018-11-28 to 2025-09-29. Get the full timeline:

Most recent: EMA Authorised: Truxima (rituximab) — Celltrion Healthcare Hungary Kft.

See pricing